Hypopigmentation Disorders

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-08-19
Clinical Trial Update: National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
EyeGENE Stage 3 expansion to broaden DNA and data repositories for rare inherited ophthalmic diseases; study currently recruiting.